Clinical Trials Browser

Phase 2 × Recurrence × axicabtagene ciloleucel × Clear all

NCT07254754 2025-11-28

LATE-R-GEL-23

Phase 2 Recruiting

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse